TP53 and neoplasm: We examined whether the p53 senescence pathway might be involved in the inhibition of tumor progression in the Amhr2-Cre;Ctnnb1Δ(ex3)/+ ovaries, which could account for the discrepancy in timing of tumor progression in these two genotypes.